V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10397367 | 10056967 | null | null | Adjuvant (A) | 2017-02-20 | 2017-02-20 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | CVP R | 101497066 |
| 10397511 | 10056968 | 1.5 | 46.1 | 03 | 2018-03-17 | 2018-03-17 | GEMCITABINE + NAB PACLITAXEL | 02 | N | PERTUZUMAB | 100559080 |
| 10397590 | 10056969 | null | null | Curative (C) | 2017-10-15 | 2017-10-25 | CHLORAMBUCIL + RITUXIMAB | 02 | N | GEMCITABINE + OXALIPLATIN | 100093561 |
| 10397618 | 10056970 | null | null | Palliative (P) | null | 2019-06-21 | Capecitabine + Mitomycin | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101547259 |
| 10397620 | 10056971 | 1.66 | 73.7 | Neo-adjuvant (N) | 2018-07-24 | 2018-08-01 | Doxorubicin chemoembolisation | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB | 100064934 |
| 10397960 | 10056972 | null | null | null | null | 2019-06-11 | ISATUXIMAB + POMALIDOMIDE | 02 | null | FLAIR TRIAL | 100798272 |
| 10398434 | 10056974 | null | null | null | 2018-01-13 | 2018-01-28 | PMitCEBO-R | 02 | null | CISPLATIN + GEMCITABINE + RITUXIMAB | 101642594 |
| 10398597 | 10056976 | null | null | Palliative (P) | null | 2015-06-23 | EC | 02 | N | DURVALUMAB | 101324660 |
| 10398606 | 10056977 | null | null | 03 | 2017-06-12 | 2018-02-24 | Doxorubicin chemoembolisation | 02 | null | CYTARABINE | 101834453 |
| 10398750 | 10056978 | 1.63 | 84.15 | Neo-adjuvant (N) | null | 2018-08-29 | null | 02 | N | VISMODEGIB | 100784661 |
| 10398787 | 10056979 | 1.64 | 84.6 | Palliative (P) | null | 2017-08-25 | VISMODEGIB | 02 | N | NILOTINIB | 101025961 |
| 10398799 | 10056980 | null | null | null | null | 2018-01-19 | BLEOMYCIN | 02 | N | ANAGRELIDE | 100281806 |
| 10398833 | 10056982 | 1.76 | 79 | null | null | 2020-03-07 | Cyclophosphamide + Docetaxel | 02 | null | GEMCITABINE + OXALIPLATIN | 101614998 |
| 10399169 | 10056984 | 1.64 | 69.9 | null | 2019-02-07 | 2019-02-28 | Gemcitabine + Oxaliplatin | null | null | TRASTUZUMAB EMTANSINE | 101588051 |
| 10399465 | 10056985 | null | null | Palliative (P) | 2021-08-12 | 2021-08-12 | Capecitabine (14 days)+Carboplatin | N | N | DOCETAXEL + GEMCITABINE | 101686926 |
| 10399600 | 10056986 | null | null | null | 2018-01-27 | 2018-01-27 | CISPLATIN + FLUOROURACIL | N | null | TOPOTECAN | 100164883 |
| 10399749 | 10056987 | null | null | null | 2019-01-13 | 2019-02-04 | ALL UKALL60+ TRIAL | null | null | NAB-PACLITAXEL | 101135681 |
| 10399766 | 10056988 | 1.8 | 96.4 | Palliative (P) | null | 2017-02-14 | CarboPEC-Taxol | N | N | CISPLATIN + CYTARABINE | 101362517 |
| 10399803 | 10056989 | 1.52 | null | Curative (C) | 2019-11-19 | 2019-12-17 | Cytarabine Low Dose | 02 | N | CARBOPLATIN + DOCETAXEL | 100479259 |
| 10400222 | 10056992 | 1.59 | 69.9 | null | null | 2019-03-04 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101630281 |
| 10400302 | 10056993 | 1.57 | 73 | null | 2017-10-15 | 2019-09-09 | Carboplatin + Pembrolizumab + Pemetrexed | null | null | BEVACIZUMAB | 100044789 |
| 10400781 | 10056994 | null | null | null | null | 2018-07-20 | Mitomycin Intravesical | 02 | null | ANAGRELIDE | 100426029 |
| 10400896 | 10056995 | 1.8 | 80 | 03 | 2019-01-06 | 2019-01-20 | Obinutuzumab + Venetoclax | 02 | N | OXALIPLATIN + RALTITREXED | 101530882 |
| 10401412 | 10056996 | null | null | null | 2018-12-03 | 2018-12-04 | LEAM | N | null | TRIAL | 100628000 |
| 10401421 | 10056997 | 1.73 | 58.4 | Palliative (P) | 2019-05-04 | 2019-05-04 | ABEMACICLIB + FULVESTRANT | 02 | N | CHLORAMBUCIL + RITUXIMAB | 101610417 |
| 10401471 | 10056998 | null | null | Palliative (P) | 2022-04-21 | 2022-04-27 | ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | null | N | PEG INTERFERON ALFA | 101132985 |
| 10401630 | 10056999 | 1.8 | 52 | null | null | 2021-10-04 | Gemcitabine + Capecitabine | 02 | null | VISMODEGIB | 100554886 |
| 10401866 | 10057002 | 1.55 | 69.9 | Palliative (P) | 2018-11-30 | 2018-11-30 | PEG INTERFERON | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 100582020 |
| 10401999 | 10057003 | null | null | Palliative (P) | 2019-11-20 | 2020-03-04 | ABVD | 02 | N | MITOMYCIN INTRAVESICULAR | 100079227 |
| 10402166 | 10057005 | null | null | Adjuvant (A) | 2016-10-07 | 2018-01-28 | null | 02 | N | MITOMYCIN | 100589648 |
| 10402271 | 10057006 | 1.6 | 68.6 | null | null | 2020-09-05 | Nilotinib | 02 | null | IRINOTECAN + MDG | 100145504 |
| 10402355 | 10057007 | null | null | null | 2022-04-05 | 2022-05-14 | CAPECITABINE + CETUXIMAB + IRINOTECAN | null | null | CTD | 100699286 |
| 10402525 | 10057010 | null | null | null | 2020-04-15 | 2020-04-17 | IDARUBICIN + MERCAPTOPURINE + METHOTREXATE + VINCRISTINE | 02 | null | DURVALUMAB | 100846645 |
| 10402629 | 10057012 | 1.54 | 66.6 | null | 2021-08-22 | 2021-08-23 | Cyclophosphamide + Docetaxel + Trastuzumab | 02 | null | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE | 100711099 |
| 10403035 | 10057014 | null | null | Neo-adjuvant (N) | 2018-10-06 | 2019-03-16 | Mitomycin Intravesical | 02 | N | TRASTUZUMAB EMTANSINE | 101644426 |
| 10403107 | 10057015 | 1.77 | 75.4 | 03 | 2018-01-11 | 2018-01-16 | null | 02 | N | CYTARABINE + ETOPOSIDE + LOMUSTINE + MELPHALAN | 101573942 |
| 10403126 | 10057016 | 1.82 | null | null | 2019-04-22 | 2019-05-07 | ABEMACICLIB + FULVESTRANT | 02 | null | DOXORUBICIN + OLARATUMAB | 100034244 |
| 10403607 | 10057018 | null | null | Palliative (P) | 2021-11-04 | 2021-11-04 | AZACITIDINE + VENETOCLAX | 02 | N | IXAZOMIB | 100177845 |
| 10403721 | 10057020 | 0.01 | 65.1 | Palliative (P) | 2019-08-23 | 2019-08-30 | CISPLATIN + FLUOROURACIL | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101230678 |
| 10404064 | 10057021 | 1.64 | 71.25 | Palliative (P) | null | 2017-09-22 | Folfirinox | 02 | N | BRENTUXIMAB | 100169733 |
| 10404140 | 10057022 | null | null | 03 | 2016-10-01 | 2016-10-02 | Capecitabine + Carboplatin + RT | 02 | N | DOXORUBICIN + OLARATUMAB | 101849160 |
| 10404166 | 10057023 | 1.78 | 64.5 | Adjuvant (A) | 2018-03-25 | 2020-09-04 | FEC | 02 | N | OXALIPLATIN + MDG | 100306446 |
| 10404173 | 10057024 | null | null | Palliative (P) | 2020-02-15 | 2020-02-20 | Cyclophosphamide + Dex + Rituximab | 02 | N | CAPECITABINE + CARBOPLATIN | 100877663 |
| 10404444 | 10057025 | null | null | Curative (C) | null | 2020-04-29 | CYCLOPHOSPHAMIDE + RITUXIMAB | 02 | null | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 101732737 |
| 10404552 | 10057026 | null | 53.2 | null | 2017-03-23 | 2017-05-19 | Ifosfamide | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100479681 |
| 10404684 | 10057028 | 1.76 | 62.85 | null | 2018-02-22 | 2019-11-28 | null | 02 | null | SUNITINIB | 101708601 |
| 10405042 | 10057029 | 1.73 | 83.7 | Palliative (P) | 2016-12-30 | 2017-10-30 | Binimetinib + Encorafenib | N | N | GEMCITABINE + NAB-PACLITAXEL | 101692462 |
| 10405141 | 10057030 | null | null | null | 2019-04-25 | 2019-04-27 | CARFILZOMIB | 02 | null | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 101737220 |
| 10405190 | 10057031 | 1.75 | 74 | Palliative (P) | 2017-09-15 | 2018-03-14 | Neratinib | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100121130 |
| 10405555 | 10057033 | 1.75 | 69.7 | null | 2017-05-24 | 2017-05-24 | Pemetrexed | null | null | BRENTUXIMAB | 101650779 |